DOCSLIB.ORG
  • Sign Up
  • Log In
  • Upload
  • Sign Up
  • Log In
  • Upload
  • Home
  • »  Tags
  • »  Xylometazoline

Xylometazoline

  • Ophthalmic Adverse Effects of Nasal Decongestants on an Experimental

    Ophthalmic Adverse Effects of Nasal Decongestants on an Experimental

  • (CD-P-PH/PHO) Report Classification/Justifica

    (CD-P-PH/PHO) Report Classification/Justifica

  • (12) Patent Application Publication (10) Pub. No.: US 2006/0110428A1 De Juan Et Al

    (12) Patent Application Publication (10) Pub. No.: US 2006/0110428A1 De Juan Et Al

  • Review of the Existing Recommendations for Essential Medicines for Ear, Nose and Throat Conditions in Adults and Children and Suggested Modifications

    Review of the Existing Recommendations for Essential Medicines for Ear, Nose and Throat Conditions in Adults and Children and Suggested Modifications

  • Conceptual Model for Using Imidazoline Derivative Solutions in Pulpal Management

    Conceptual Model for Using Imidazoline Derivative Solutions in Pulpal Management

  • Package Leaflet

    Package Leaflet

  • S1 Figa

    S1 Figa

  • World Health Organization Model List of Essential Medicines, 21St List, 2019

    World Health Organization Model List of Essential Medicines, 21St List, 2019

  • How Toxic Indeed Is Oxymetazoline? Collection and Comparison of Toxicological Data of Pharmacologically Active Imidazoline Derivatives

    How Toxic Indeed Is Oxymetazoline? Collection and Comparison of Toxicological Data of Pharmacologically Active Imidazoline Derivatives

  • OTC Medicine Monograph: Topical Nasal Decongestants

    OTC Medicine Monograph: Topical Nasal Decongestants

  • Federal Register / Vol. 60, No. 80 / Wednesday, April 26, 1995 / Notices DIX to the HTSUS—Continued

    Federal Register / Vol. 60, No. 80 / Wednesday, April 26, 1995 / Notices DIX to the HTSUS—Continued

  • (12) United States Patent (10) Patent No.: US 8,158,152 B2 Palepu (45) Date of Patent: Apr

    (12) United States Patent (10) Patent No.: US 8,158,152 B2 Palepu (45) Date of Patent: Apr

  • Type of the Paper (Article

    Type of the Paper (Article

  • Pharmacology

    Pharmacology

  • DRUGS POTENTIALLY AFFECTING MIBG UPTAKE Rev. 26 Oct 2009

    DRUGS POTENTIALLY AFFECTING MIBG UPTAKE Rev. 26 Oct 2009

  • Decongestants and Your Nose

    Decongestants and Your Nose

  • A Computational Tool for Pathway-Based Rational Drug Repositioning Supplementary Information

    A Computational Tool for Pathway-Based Rational Drug Repositioning Supplementary Information

  • The Selection and Use of Essential Medicines

    The Selection and Use of Essential Medicines

Top View
  • Stembook 2018.Pdf
  • 4-Adrenergic Agonists.Pdf
  • Drugs/Medications Known to Cause Hyperhidrosis Certain Prescriptions
  • Package Leaflet
  • WO 2009/065116 Al
  • Prohibited List 2021
  • Public Assessment Report Scientific Discussion Orinox HA 1 Mg/Ml
  • Medicines Formulary
  • Harmonized Tariff Schedule of the United States (2004) -- Supplement 1 Annotated for Statistical Reporting Purposes
  • Survey of State Boards of Pharmacy on The
  • Product List
  • Chemical Structure-Related Drug-Like Criteria of Global Approved Drugs
  • Federal Register/Vol. 77, No. 16/Wednesday, January 25, 2012
  • Ten Days' Use of Oxymetazoline Nasal Spray with Or Without
  • Electronic Supplementary Material (ESI) for Organic & Biomolecular
  • A Comparison of Xylometazoline (Otrivine) and Phenylephrine
  • Non-Target Screening ‒ a Powerful Tool for Selecting Environmental Pollutants
  • Editor's Notes Rofecoxib


© 2024 Docslib.org    Feedback